A single-center randomized controlled study of Vonoprazan based dual therapy and Rabeprazole based dual therapy for Helicobacter pylori infection.
A randomized, double-blind, placebo-controlled clinical study for 52 weeks to evaluate the effect of recombinant anti human GLP-1 receptor humanized monoclonal antibody injection on blood glucose fluctuation and bone metabolism in patients with type 2 diabetes
Correlation between time interval after gastric emptying with ultrasound assessment and quality of bowel cleansing in patients undergoing painless colonoscopy: a randomized, prospective,controlled trial
100 Clinical Results associated with NanJing First Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with NanJing First Pharmaceutical Co., Ltd.
100 Deals associated with NanJing First Pharmaceutical Co., Ltd.
100 Translational Medicine associated with NanJing First Pharmaceutical Co., Ltd.